Introduction {#s01}
============

Cells detect and respond to extracellular stimuli through cell-surface receptors. Ligand-bound receptors are internalized from the plasma membrane into the endosomal system, which is composed of a tubulovesicular network of polymorphic intracellular compartments. Receptors are transferred along this network in a spatially and temporally controlled manner to achieve different itineraries and specific signaling outputs ([@bib47]; [@bib14]; [@bib28]). Neurons are highly sensitive to alterations in endosomal trafficking due to their compartmentalized morphology. The endocytic/endosomal system regulates neuronal growth and survival signaling via internalization and turnover of signaling receptors at synapses, as well as via long-distance axonal transport of receptor-containing endosomes to neuronal cell bodies ([@bib17]; [@bib4]; [@bib52]). Regulation of these events depends on endosomal maturation, which is driven by changes in the lipid and protein composition of the endosome ([@bib34]).

Sorting Nexins (SNXs) are an important family of endosomal proteins, characterized by the presence of a phosphoinositide-binding Phox homology (PX) domain. SNXs participate in a variety of cellular processes, ranging from clathrin-mediated endocytosis to endosomal sorting and signaling to lipid metabolism ([@bib13]; [@bib58]; [@bib9]). These diverse roles are achieved by coordination of the PX domain with their other functional domains ([@bib25]; [@bib46]; [@bib59]; [@bib38]; [@bib10]). However, the molecular and cellular mechanisms of many SNXs remain unexplored.

SNX16 has been implicated in regulating receptor traffic and signaling in both mammalian cells and *Drosophila melanogaster* ([@bib23]; [@bib11]; [@bib49]; [@bib16]). SNX16 contains a PX domain that binds specifically to phosphatidylinositol 3-phosphate (PI(3)P), as well as a C-terminal coiled-coil (CC) domain, which is required for its self-association in vivo ([@bib23]; [@bib11]; [@bib10]) and mediates dimerization in the SNX16 crystal structure ([@bib62]). However, the mechanisms by which the CC domain contributes to the cellular functions of SNX16 are unknown. *Drosophila* SNX16 (dSNX16) promotes synaptic growth signaling via activated bone morphogenetic protein (BMP) receptors in presynaptic terminals at the neuromuscular junction (NMJ; [@bib49]). The F-BAR protein Nervous Wreck (Nwk) acts upstream of dSNX16 to constrain synaptic growth signaling, and this negative regulation is suppressed by mutating three highly conserved glutamates to alanines within the dSNX16 CC domain ([Fig. 1 A](#fig1){ref-type="fig"}; E347A, E350A, and E351A; hereafter referred to as dSNX16^3A^). Overexpression of dSNX16^3A^ in *Drosophila* resulted in dramatic synaptic overgrowth and mislocalization of activated BMP receptors at the NMJ ([@bib49]), the opposite of the *dSnx16* loss-of-function phenotype, suggesting that dSNX16^3A^ is dominant active. The mechanisms by which CC-dependent activities of dSNX16^3A^ regulate neuronal endosomal traffic to promote signaling remain unclear.

![**PI(3)P-dependent lipid binding of hSNX16 CC domain mutants. (A)** Schematic of hSNX16 constructs. **(B)** Location of hSNX16 CC mutations on hSNX16 PX-CC dimer (PDB accession number [5GW0](5GW0); [@bib62]). CC domains are shown in green and glutamates in magenta. **(C--F)** Liposome cosedimentation assays. Purified hSNX16 variants were incubated with liposomes of the indicated composition and pelleted. Representative Coomassie staining of supernatant (S) and pellet (P) fractions is shown in C and E. **(C and D)** Liposomes composed of 80% DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), 15% DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), 5% DOPS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine), and PI(3)P (0.5%, 1%, 2.5%, 5%, and 10%; with a corresponding decrease in DOPC). PI(3)P-dependent lipid binding of purified hSNX16 CC domain mutants is not significantly different from wild-type hSNX16. Y145A mutsation abolishes PI(3)P binding of hSNX16 as previously reported ([@bib11]). **(E and F)** Binding of wild-type hSNX16 is more salt sensitive than hSNX16^3A^. Liposomes (70% DOPC, 15% DOPE, 5% DOPS, and 10% PI(3)P) were incubated for 45 min with purified hSNX16 and the indicated NaCl concentrations before pelleting. In the last condition, hSNX16 and liposomes were incubated in 100 mM NaCl for 30 min, and then NaCl was added to a final concentration of 400 mM for 15 min before pelleting. Quantification is a result of three independent experiments, analyzed using a Kruskal--Wallis test followed by a Dunn's multiple comparisons test. Data are presented as mean ± SEM. \*, P \< 0.05. ns, not significant.](JCB_201811074_Fig1){#fig1}

Additional findings suggest an important role of the CC domain in SNX16 regulation. Human SNX16 (hSNX16) localizes to recycling and tubular late endosomes in addition to PI(3)P-rich early endosomes in immortalized cell lines ([@bib23]; [@bib11]; [@bib35]; [@bib7]; [@bib65]; [@bib62]), suggesting that PI(3)P binding is not sufficient to explain its endosome association. Deleting a fragment containing the CC domain results in hSNX16 loss from later endosomes and delays trafficking of internalized EGF ([@bib23]), highlighting the functional importance of the hSNX16 CC domain. Furthermore, the SNX16 PX domain and CC domain jointly contribute to the interaction with PI(3)P at the entrance to the PI(3)P-binding pocket ([@bib62]). Interestingly, two of the three key residues from the CC domain (E234, E235, and Y238) shaping this entrance map to E350 and E351 in dSNX16, which are mutated in dominant-active mutant dSNX16^3A^ ([Fig. 1 B](#fig1){ref-type="fig"}; [@bib49]; [@bib62]).

In this study, we address the role of the SNX16 CC domain in regulating its molecular and cellular functions in vitro using purified proteins and synthetic liposomes and in vivo in cultured mammalian cells and *Drosophila* motor neurons.

Results {#s02}
=======

hSNX16 CC variants do not strongly affect PI(3)P binding {#s03}
--------------------------------------------------------

The structure of hSNX16 suggests that its CC domain could contribute to entrance of PI(3)P into the PX domain--binding pocket ([@bib62]). To understand the role of the SNX16 CC domain in more detail, we purified wild-type hSNX16, a hSNX16 variant missing the full CC domain (hSNX16^ΔCC^), mutant hSNX16^3A^ (E231A, E234A, and E235A), as well as a PX domain PI(3)P-binding pocket mutant hSNX16^Y145A^ ([@bib11]) as a negative control ([Fig. 1, A and B](#fig1){ref-type="fig"}). We then tested PI(3)P binding of different CC variants in liposome cosedimentation assays ([Fig. 1, C and D](#fig1){ref-type="fig"}). Wild-type hSNX16 cosedimented more effectively with increasing PI(3)P concentration, and hSNX16^Y145A^ abolishes PI(3)P binding, as previously shown ([@bib11]). By contrast, PI(3)P-binding sensitivities of hSNX16^ΔCC^ and hSNX16^3A^ were not significantly different from hSNX16 ([Fig. 1 D](#fig1){ref-type="fig"}), suggesting that the CC domain does not strongly modulate the lipid-binding affinity of SNX16.

We next tested if electrostatic interactions mediate the binding of hSNX16 and our CC variants to the membrane by conducting liposome cosedimentation assays in the presence of 400 mM NaCl. hSNX16 binding to 10% PI(3)P liposomes was reduced in the presence of NaCl. However, once bound to liposomes, hSNX16 was resistant to 400 mM NaCl, suggesting that the initial binding step is sensitive to electrostatic interactions, followed by more hydrophobically driven effects. Interestingly, though hSNX16^3A^ exhibited similar lipid binding to hSNX16 at 10% PI(3)P, hSNX16^3A^ binding was not sensitive to 400 mM NaCl ([Fig. 1, E and F](#fig1){ref-type="fig"}), suggesting that the CC domain may be involved in these hydrophobic interactions. These results raise the possibility that the CC domain of hSNX16 functions in parallel to the canonical PI(3)P-binding PX domain to mediate membrane association.

hSNX16 oligomerizes into higher-order assemblies via its CC domain {#s04}
------------------------------------------------------------------

Since the hSNX16 CC domain mediates its homo-oligomerization ([@bib23]; [@bib11]), we hypothesized that altered salt sensitivity of hSNX16^3A^ may be due to changes in self-association. To test this hypothesis, we incubated hSNX16 CC variants with 1% PI(3)P liposomes and increasing concentrations of the 8-atom-long lysine cross-linker BS^3^ and conducted cosedimentation assays ([Fig. 2, A and B](#fig2){ref-type="fig"}). In the liposome-containing pellet, hSNX16 formed cross-linked species at the molecular weight of dimers (∼100 kD; [Fig. 2, A and B](#fig2){ref-type="fig"}, white triangle) as well as unexpected higher-order species (\>200 kD; red triangle). hSNX16^ΔCC^ produced minimal higher-order species, though we did observe dimers, consistent with previous findings that the PX domain contributes to self-association ([@bib11]). By contrast, hSNX16^3A^ exhibited more abundant cross-linking than wild-type hSNX16 into higher-order species ([Fig. 2 A](#fig2){ref-type="fig"}), though total cosedimentation with PI(3)P was similar to hSNX16 and hSNX16^ΔCC^ (Fig. S1, A and B). In the supernatant fraction, we also observed higher-order assemblies of hSNX16 and hSNX16^3A^ and only dimer species of hSNX16^ΔCC^ ([Fig. 2 B](#fig2){ref-type="fig"}). Interestingly, hSNX16^3A^ supernatants lacked the dimer species and only showed higher-order assemblies. We then asked if these oligomers required the presence of membranes by conducting cross-linking assays in buffer alone. In contrast to liposome-containing cross-linking experiments, in the absence of liposomes, hSNX16 and hSNX16^3A^ showed comparable dimer and higher-order assembly formation (Fig. S1 C), suggesting that oligomerization of hSNX16^3A^ is potentiated by membranes. Taken together, we conclude that hSNX16 can oligomerize into higher-order assemblies via its CC domain and that hSNX16^3A^, a mutant in the CC domain, promotes the formation of these assemblies.

![**hSNX16 oligomerizes into higher-order assemblies on membranes via its CC domain. (A and B)** hSNX16^ΔCC^ reduces and hSNX16^3A^ promotes self-association compared with hSNX16^WT^ on PI(3)P liposomes. 5 µM purified hSNX16, hSNX16^3A^, or hSNX16^ΔCC^ were incubated with 1% (5 µM) PI(3)P liposomes followed by BS^3^ cross-linking, and then tested for liposome cosedimentation. **(A)** Coomassie-stained gels of cross-linked high-molecular-weight assemblies in protein--liposome pellets with increasing BS^3^ concentration (125 nM, 2.5 µM, 5 µM, 12.5 µM, and 25 µM). **(B)** Coomassie-stained gels of unbound proteins in the lipid cosedimentation assay from same experiments as in A. Black, white, and red triangles point to monomers, dimers, and higher-order assemblies, respectively. **(C)** Schematic of the GUV assay**. (D--F)** hSNX16^3A^ fails to recover after photobleaching at lower protein concentrations compared with wild-type hSNX16, while hSNX16^ΔCC^ retains high mobility at all concentrations measured. **(D)** Representative time-lapse images of 100 nM hSNX16 and hSNX16^3A^ before and after photobleaching. **(E and F)** Quantification of protein and lipid fluorescence of GUVs bound by hSNX16 variants at 100 nM and 500 nM. Protein and lipid fluorescence were normalized to a nonbleached region on the same GUV to correct for photobleaching. Protein fluorescence was then further normalized by subtracting from all time points the intensity at t = 0 and normalizing prebleach intensity to 1. Quantification is from five GUVs incubated with 100 nM hSNX16; six GUVs incubated with 100 nM hSNX16^3A^, 500 nM hSNX16, or 500 nM hSNX16^ΔCC^; and eight GUVs incubated with 500 nM hSNX16^3A^. Data are presented as mean ± SEM. Scale bars, 10 µm.](JCB_201811074_Fig2){#fig2}

To further explore hSNX16 higher-order assembly, we conducted FRAP experiments on giant unilamellar vesicles (GUVs) coated with SNAP^488^-labeled hSNX16 variants ([Fig. 2 C](#fig2){ref-type="fig"}). All hSNX16 variants coated GUVs uniformly and did not exhibit localized clustering. At 100 nM, hSNX16^3A^ failed to recover after photobleaching a region of the GUV, while hSNX16 recovered rapidly ([Fig. 2, D and E](#fig2){ref-type="fig"}). At 500 nM, hSNX16 and hSNX16^3A^ both failed to recover after photobleaching, while hSNX16^ΔCC^ remained mobile, suggesting that hSNX16 higher-order assemblies form a stable scaffold on GUV via the CC domain and that the hSNX16^3A^ mutant promotes these stable assemblies, consistent with our cross-linking results ([Figs. 2 E](#fig2){ref-type="fig"} and S1 D). In addition, labeled phosphatidyl-ethanolamine (PE) in the photobleached region recovered rapidly for all hSNX16 CC variants, indicating that this component of the membrane remained fluid even when the protein assembly did not ([Fig. 2 F](#fig2){ref-type="fig"}). Considering both the cross-linking and the GUV FRAP results, we conclude that hSNX16 can oligomerize into higher-order structures (beyond dimers) via its CC domain and that the hSNX16^3A^ mutant and membrane binding together increase the formation of these oligomers.

hSNX16 higher-order assemblies promote membrane tubulation {#s05}
----------------------------------------------------------

When conducting the FRAP experiments with 500 nM hSNX16 variants, we consistently observed tubule formation on GUVs coated with hSNX16 and hSNX16^3A^, but not hSNX16^ΔCC^ (Fig. S1 D). This was unexpected, since SNX16 does not contain a Bin/Amphiphysin/Rvs167 (BAR)--domain scaffold like other membrane-tubulating SNXs ([@bib59]) and instead forms a scissor-shaped homodimer ([@bib62]). To investigate this novel membrane tubulation activity of hSNX16, we incubated hSNX16 CC variants with GUVs of various PI(3)P compositions and quantified GUV morphology ([Fig. 3, A and B](#fig3){ref-type="fig"}). We did not observe tubules on 0% PI(3)P GUVs incubated with hSNX16 or on GUVs without protein. By contrast, hSNX16 generated tubules on 10% PI(3)P GUVs at 100 nM, and the number of tubulated GUVs increased at 500 nM hSNX16 ([Fig. 3, A and B](#fig3){ref-type="fig"}). Notably, hSNX16^3A^ generated tubules at lower PI(3)P and protein concentrations than hSNX16, and hSNX16^ΔCC^ failed to generate tubules under any tested conditions ([Fig. 3, A and B](#fig3){ref-type="fig"}). Thus, the tubulation activity of hSNX16 and our CC variants correlated with their capability to form higher-order assemblies in cross-linking and FRAP assays.

![**hSNX16 generates membrane tubules via its CC region. (A)** Representative single confocal slices of rhodamine PE--labeled GUVs (0%, 1% \[30 nM\], or 10% \[300 nM\] PI(3)P) incubated with 100 nM or 500 nM hSNX16 CC variants. Scale bars, 10 µm. **(B)** Percentage of tubulated vesicles at the indicated PI(3)P and hSNX16 concentrations. Quantification is from at least 20 GUVs per condition. **(C)** Negative-stain EM of liposomes incubated with buffer, hSNX1, or hSNX16 CC variants (2 µM final protein concentration). Two representative fields are shown for each condition. Scale bar, 400 nm.](JCB_201811074_Fig3){#fig3}

Because GUVs are cell-sized vesicles that are essentially flat at the scale of individual proteins, we next tested whether hSNX16 promotes membrane tubulation on smaller, endosome-size vesicles using negative-stain EM. After incubation with 200 nm liposomes, hSNX16 and hSNX16^3A^ exhibited tubulation comparable to the BAR domain--containing SNX1 ([Fig. 3 C](#fig3){ref-type="fig"}), while hSNX16^ΔCC^ did not exhibit tubulation. Thus, hSNX16 generates membrane tubules via its CC domain, and this membrane tubulation activity correlates with higher-order assembly. Taken together, our in vitro data indicate that the CC domain is required for hSNX16 higher-order assembly and membrane-deforming activities and that the hyperoligomerized mutant hSNX16^3A^ promotes these activities.

hSNX16 CC variants control endosome association in vivo {#s06}
-------------------------------------------------------

To investigate the importance of hSNX16 oligomerization in vivo, we next tested the subcellular localization of hSNX16 CC variants in cells. hSNX16 exhibited both punctate and cytoplasmic localization, and some puncta were elongated or tubulated, as previously reported ([Fig. 4](#fig4){ref-type="fig"}; [@bib11]; [@bib7]; [@bib62]). One previous study found that deletion of a hSNX16 fragment longer than but including the CC domain (aa 214--295) resulted in its loss from late endosomes while preserving early endosome localization in A431 cells ([@bib23]). We further found that a more precise deletion of the CC domain (aa 230--278) resulted in partial loss of hSNX16 from punctate structures and net redistribution to the cytoplasm in cultured rat hippocampal neurons ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast, hSNX16^3A^ exhibited enhanced punctate localization and was depleted from the cytosol. To understand whether this subcellular localization of hSNX16 CC variants is unique to neurons, we tested multiple mammalian cell lines and observed similar results, suggesting a general role for CC domain--promoted oligomerization in hSNX16 endosomal localization ([Fig. 4 B](#fig4){ref-type="fig"}). Further, the puncta found in all hSNX16 CC variants partially colocalized with early endosome antigen 1 (EEA1), consistent with previous findings that SNX16 distributes among early and late endosomes ([@bib11]; [@bib7]; [@bib62]). We further quantified the change in hSNX16^3A^ subcellular localization and found that it was significantly more clustered than hSNX16, as measured both by an increase at the neuronal cell body of coefficient of variation (CoV; or standard deviation/mean intensity, reflecting a nonuniform distribution of pixel intensities), as well as a larger fraction of high-intensity pixels in HeLa cells ([Fig. 4, C and D](#fig4){ref-type="fig"}). Thus, we conclude that the hSNX16 CC domain is required for its proper endosomal localization in vivo and that the hSNX16^3A^ mutant, which exhibits enhanced oligomerization in vitro, also promotes hSNX16 endosome localization.

![**hSNX16 CC mutants exhibit altered subcellular localization in vivo.** hSNX16^ΔCC^ reduces and hSNX16^3A^ enhances hSNX16 punctate localization in mammalian cells. **(A)** Representative images of cell body and neurites from immunostained DIV 7 rat hippocampal neurons transiently expressing the indicated myc-hSNX16 variants. **(B)** Representative images of the indicated cell lines expressing indicated hSNX16 CC variants and fixed 24 h after transfection. hSNX16-transfected U2OS cells were stained with α-EEA1 antibodies. **(C)** CoV (standard deviation/mean of pixel intensities) of myc-hSNX16 CC mutants in hippocampal cell bodies. Quantification is from ≥35 neurons per condition from three independent coverslips, tested for normality and analyzed using a one-way ANOVA followed by Tukey's test. **(D)** Histograms depict fraction of pixels at the indicated intensities for hSNX16 and hSNX16^3A^ in HeLa cells. Quantification is from 14 cells per condition and analyzed using a Mann--Whitney *U* test within each bin. All images show 2D maximum intensity projections of confocal stacks. Data are shown as box-and-whisker plots with all data points superimposed in C and as mean + SEM in D. \*, P \< 0.05; \*\*\*, P \< 0.001. ns, not significant. Scale bars, 10 µm.](JCB_201811074_Fig4){#fig4}

dSNX16 CC variants control localization and tubulation of compartments in *Drosophila* motor neurons {#s07}
----------------------------------------------------------------------------------------------------

Previously, we reported that null mutants of *dSnx16* cause reduced synaptic growth at the *Drosophila* NMJ and that *dSnx16*^3A^ acts as a dominant-active mutant and exhibits a synaptic overgrowth phenotype ([@bib49]). We therefore examined how the SNX16 CC-mediated oligomerization behavior that we observed in the mammalian system could contribute to its functional role at the *Drosophila* NMJ. We first tested whether the in vivo change in subcellular localization that we observed in mammalian cells is conserved. We generated transgenic fly lines with SNAP-tagged dSNX16 CC variants, each inserted into the same genetic locus, and used the binary GAL4/UAS system to examine their localization upon expression in *Drosophila* larval motor neurons. This allowed us to examine localization within different neuronal structures, including cell bodies and dendrites in the ventral ganglion, axons bundled in segmental nerves, and NMJ axon terminals embedded at the surface of the muscle (see Fig. S2 A for a schematic). dSNX16 primarily localized to punctate structures at the NMJ ([Fig. 5 A](#fig5){ref-type="fig"}), which, as we previously described, correspond to endosomes ([@bib49]). Further, we found that similar to hSNX16 localization in mammalian cells, dSNX16 exhibited both cytoplasmic and punctate localization in axons proximal to the ventral ganglion, as well as in the cell bodies. Deletion of the dSNX16 CC domain resulted in increased cytoplasmic localization, while dSNX16^3A^ exhibited enhanced punctate localization, similar to our observations for hSNX16 ([Fig. 5, A and C](#fig5){ref-type="fig"}), indicating that the function of the CC domain in SNX16 localization is conserved. Furthermore, via structured illumination microscopy (SIM) of neuronal cell bodies, we found that dSNX16 localized to tubulated structures ([Fig. 5 B](#fig5){ref-type="fig"}). This tubule localization was CC domain dependent, and an increased number of tubulated compartments were observed in the cell body of dSNX16^3A^-expressing animals, correlating with the tubulation activity of hSNX16 CC variants in vitro. We next measured the intensity of dSNX16 CC variants at the NMJ, proximal axon, and cell body and found that dSNX16^3A^ was specifically enriched at the cell body, while dSNX16^ΔCC^ exhibited overall decreased intensity ([Fig. 5 D](#fig5){ref-type="fig"}). The enhanced punctate localization and cell body enrichment of dSNX16^3A^ was also observed for randomly integrated UAS-dSNX16-GFP P-element lines with different expression levels (Fig. S2, B--D; [@bib49]). These results suggest that in *Drosophila* motor neurons, where SNX16 positively regulates synaptic growth signaling, dSNX16 CC variants control the abundance, distribution, and structure of endosomes.

![**dSNX16 CC variants alter endosome structure, localization, and distribution in larval motor neurons. (A and B)** Representative images of animals expressing indicated UAS-*dSnx16*-SNAP variants driven by VGlut-GAL4. Shown are muscle 4 NMJ, proximal axons (within 100 µm of the ventral ganglion), and MNISN-I cell bodies (motor neuron in the intersegmental nerve I \[[@bib12]\]; see Fig. S2 A for schematics). dSNX16^ΔCC^ reduces and dSNX16^3A^ enhances dSNX16 punctate localization. dSNX16^3A^ levels are increased at the cell body and reduced at the NMJ. **(B)** dSNX16 localizes tubular structures at the cell body revealed by SIM. dSNX16^ΔCC^ reduces and dSNX16^3A^ increases the quantity of tubulated SNX16 compartments. **(C and D)** CoV and mean intensity quantification of dSNX16-SNAP^JF549^. Quantification is from ≥20 NMJs, 42 axons, or 65 cell bodies and analyzed using a Kruskal--Wallis test followed by Dunn's multiple comparisons test. Intensities were normalized to the mean intensity in the wild-type dSNX16 condition. All images show 2D maximum intensity projections of confocal stacks unless noted otherwise. Data are shown as box-and-whisker plots with all data points superimposed. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. Scale bars, 10 µm.](JCB_201811074_Fig5){#fig5}

dSNX16 CC variants alter BMP receptor localization and signaling {#s08}
----------------------------------------------------------------

dSNX16 colocalizes with and controls the activity of the BMP signaling pathway receptor Thickveins (Tkv) at the NMJ ([@bib49]). To understand the functional relevance of the altered distribution of dSNX16 CC variants, we examined their effects on BMP-dependent synaptic growth. We previously found that NMJ signaling by a constitutively active BMP receptor (Tkv^Q199D^; [@bib26]) was highly sensitive to the SNX16 pathway ([@bib49]). We expressed Tkv^Q199D^ in motor neurons together with dSNX16 CC variants in an otherwise wild-type background and found that both dSNX16^3A^ and (to a lesser extent) dSNX16^ΔCC^ caused an increased number of boutons relative to controls ([Fig. 6 A](#fig6){ref-type="fig"}). We further measured the levels of phosphorylated Mad (pMad), a downstream target of the BMP pathway that translocates into nuclei upon activation ([@bib40]; [@bib41]; [@bib48]), and found that both dSNX16^3A^ and dSNX16^ΔCC^ led to elevated pMad in motor neuron nuclei compared with wild-type dSNX16 ([Fig. 6, B and C](#fig6){ref-type="fig"}).

![**dSNX16 CC variants regulate endosomal localization of Tkv to promote BMP signaling. (A)** Quantification of the mean bouton number on muscle 4 in animals expressing VGlut-driven UAS-*Tkv*^Q199D^ and UAS-*dSnx16*-SNAP variants. **(B)** Representative images of α-pMad--stained animals expressing VGlut-driven *Tkv*^Q199D^ and *dSnx16*-SNAP variants in the ventral nerve cords. **(C)** Quantification of pMad intensity measured from single, central slices of dSNX16-positive cell bodies. **(D)** Representative images of animals expressing VGlut-driven *Tkv*-mCherry and *dSnx16*-SNAP variants at the muscle 4 NMJ, proximal axon, and cell body. **(E)** Representative axonal transport kymograph of VGlut-driven *Tkv*-mCherry and *dSnx16*-GFP (corresponds to Video 1). Arrowhead indicates a dSNX16 particle containing Tkv, and yellow box highlights the retrograde movement of this particle over time. **(F)** PCCs between Tkv-mCherry and dSNX16 CC variants. **(G)** Mean intensity quantification of Tkv-mCherry. **(H)** Representative SIM images of animals expressing VGlut-driven Tkv-mCherry and the indicated dSNX16-GFP in the cell body. dSNX16^3A^-GFP (low) and dSNX16^3A^-GFP (high) lines correspond to dSNX16^3A^-GFPIIA and dSNX16^3A^-GFPIIIF lines in Fig. S2. Arrowheads indicate tubular dSNX16 compartments that do not contain Tkv. Quantification is from ≥21 NMJs, 37 axons, or 61 cell bodies analyzed using Kruskal--Wallis tests followed by Dunn's multiple comparisons test. All intensity measurements were normalized to mean intensity in the wild-type dSNX16 condition. All images show 2D maximum intensity projections of confocal stacks. Data are shown as box-and-whisker plots with all data points superimposed. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. ns, not significant. Scale bars, 10 µm; or 2 µm in the zoomed-in view of H.](JCB_201811074_Fig6){#fig6}

How could both tubulating and nontubulating forms of dSNX16 promote synaptic growth, and how does this relate to their subcellular distribution? To answer these questions, we first examined the colocalization of dSNX16 and mCherry-tagged Tkv throughout the neuron ([Fig. 6, D and E](#fig6){ref-type="fig"}). Wild-type dSNX16 partially colocalized with Tkv in fixed cell bodies, axons, and NMJs ([Fig. 6 D](#fig6){ref-type="fig"}). To explore the relationship between dSNX16 and Tkv in different parts of the neuron, we examined their transport by live imaging of axons ([Fig. 6 E](#fig6){ref-type="fig"} and Videos 1 and 2). Most Tkv particles are motile in both directions, as we and others previously described ([@bib54]; [@bib29]; [@bib18]). In 11 (4-min) recordings from eight animals, we counted 136 dSNX16-positive particles (66.2% stationary, 11.7% anterograde, and 22.1% retrograde). We observed only 13 cotransporting dSNX16 and Tkv particles. 10 out of 13 of these particles moved in the retrograde direction, and 3 out of 13 were stationary, indicating that dSNX16-Tkv particles are biased to motility in the retrograde direction relative to dSNX16-only particles. These results are consistent with the idea that SNX16 transits from the NMJ to the cell body with cargo but do not rule out that Tkv may accumulate on SNX16 endosomes in the cell body independent of retrograde endosome transport.

We then examined the colocalization of Tkv-mCherry and dSNX16 CC variants. Interestingly, despite our observation that dSNX16^ΔCC^-SNAP was expressed at overall lower levels and had higher diffuse signal relative than dSNX16 ([Fig. 5, C and D](#fig5){ref-type="fig"}) and that overall Tkv levels were reduced at dSNX16^ΔCC^-expressing cell bodies, we found that dSNX16^ΔCC^ had a similar Pearson correlation coefficient (PCC) to wild-type dSNX16 with Tkv-positive endosomes in the cell body and axon ([Fig. 6 F](#fig6){ref-type="fig"}). This result suggests that Tkv is enriched in dSNX16^ΔCC^-positive endosomes in the cell body relative to the rest of the neuron. dSNX16^3A^-SNAP colocalization with Tkv was strongly increased compared with wild-type SNX16, concomitant with increased Tkv intensity at the cell body and axon ([Fig. 6, F and G](#fig6){ref-type="fig"}), the opposite effect from dSNX16^ΔCC^. We corroborated these results using two different dSNX16^3A-^GFP lines (to control for the effects of expression levels) and found that the stronger dSNX16^3A-^GFP line also exhibited enhanced colocalization with Tkv and Tkv accumulation at the NMJ, proximal axon, and cell body compared with wild-type dSNX16-GFP, while the weaker dSNX16^3A-^GFP line only promoted Tkv accumulation in the cell body (Fig. S3, A--C). These results suggest that BMP signaling components in the cell body are most sensitive to the effects of dSNX16^3A^. We therefore used SIM to examine Tkv localization within dSNX16-coated endosomes in the cell body and observed that although Tkv was found in the vacuolar compartment of dSNX16- or dSNX16^3A^-positive endosomes, it was strikingly absent from dSNX16- or dSNX16^3A^-decorated tubules ([Fig. 6 H](#fig6){ref-type="fig"}, arrowheads). Taken together, our results indicate that dSNX16 CC variants promote Tkv traffic and BMP signaling by altering endosomal localization and cell body levels of Tkv by different mechanisms.

We then asked whether the effects of dSNX16 CC variants on Tkv are specific to this cargo or could be generalized to other cargoes by examining the distribution of exogenously expressed human Transferrin receptor (hTfR; Fig. S3 D). We found that motor neuron--expressed hTfR localizes to puncta in the cell body and NMJ and also traffics into postsynaptic structures that are likely to be endosome-derived exosomes ([@bib32], [@bib33]), which is consistent with previous descriptions of transferrin receptor as a canonical exosome cargo ([@bib44]). We found an increased colocalization of hTfR with dSNX16^3A^ and decreased colocalization with dSNX16^ΔCC^ in the cell body, consistent with the levels and distribution of dSNX16 variants in these compartments ([Fig. 5, C and D](#fig5){ref-type="fig"}). However, we found no changes in overall levels of hTfR in the cell body or NMJ, suggesting that the effect on Tkv levels is specific (Fig. S3, E and F).

dSNX16 association with endosomal compartments differs between the NMJ and cell body {#s09}
------------------------------------------------------------------------------------

Our results indicate that the dSNX16 CC variants may have distinct effects on endosomes in different regions of neurons. To further understand the nature of dSNX16 puncta in these regions, we examined the colocalization of dSNX16 with previously described dSNX16-associated markers Rab5 (early endosomes), Rab7 (late endosomes), and Rab11 (recycling endosomes) in the cell body, axon, and NMJ ([Fig. 7, A and B](#fig7){ref-type="fig"}; and Fig. S4, A and B), using endogenously tagged Rabs or antibodies, to avoid effects of overexpressing tagged transgenes. However, we could not measure colocalization between dSNX16 with Rab5, Rab7, or Rab11 in axons, since unlike the NMJ and cell body, we could not segment the motor neurons in which dSNX16 was expressed away from the many additional cell types in the nerve bundle in which endogenous Rab proteins are found (Fig. S4 B). As we previously reported ([@bib49]), at the NMJ, we found dSNX16 localized to Rab5-positive early endosomes ([Fig. 7, A and C](#fig7){ref-type="fig"}). Here we report that at the NMJ, dSNX16 colocalized poorly with Rab7-positive late endosomes. By contrast, in the cell body, dSNX16 localized to both Rab5-positive and Rab7-positive puncta, suggesting different maturation states of dSNX16 containing endosomes at the nerve terminal compared with the cell body ([Fig. 7, B and D](#fig7){ref-type="fig"}). dSNX16 did not specifically colocalize with Rab11 in puncta in any region of the neuron, although strong diffuse Rab11 signal at the NMJ may produce an artificially high PCC ([Fig. 7, C and D](#fig7){ref-type="fig"}; and Fig. S4 A).

![**The dSNX16 CC domain regulates its endosomal localization specifically in the cell body. (A and B)** Representative images of animals expressing VGlut-GAL4--driven *dSnx16*-SNAP transgenes. **(C)** PCCs between dSNX16 and Rab5, Rab7, α-Rab11 immunoreactivity, or UAS-GFP-myc-2xFYVE at the NMJ. **(D)** PCC between dSNX16 and endogenous GFP-Rab5, YFP-Rab7, α-Rab11 immunoreactivity, or UAS-GFP-myc-2xFYVE in the cell body. **(E)** Mean intensity quantification of Rab5, Rab7, and FYVE at the NMJ. **(F)** Mean intensity quantification of Rab5, Rab7, and FYVE in the cell body. Quantification is from ≥21 NMJs or 52 cell bodies, analyzed using a Kruskal--Wallis test followed by Dunn's multiple comparisons test. Intensity measurements were normalized to mean intensity in the wild-type dSNX16 condition. All images show 2D maximum intensity projections of confocal stacks. Data are shown as box-and-whisker plots with all data points superimposed. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. ns, not significant. Scale bars, 10 µm.](JCB_201811074_Fig7){#fig7}

We then examined the colocalization of dSNX16 CC variants with Rab-marked endosomes. In the cell body, dSNX16^ΔCC^ colocalized more poorly than wild-type dSNX16 with Rab5 and Rab7 ([Fig. 7, B and D](#fig7){ref-type="fig"}). By comparison, at the NMJ, dSNX16^ΔCC^ colocalized with Rab5 similarly to wild-type dSNX16, suggesting that it may actually be enriched on NMJ early endosomes relative to its distribution elsewhere ([Fig. 7, A and C](#fig7){ref-type="fig"}). By contrast, dSNX16^3A^ exhibited increased colocalization in the cell body with Rab5-positive endosomes and to an even greater extent with Rab7-positive endosomes relative to wild-type dSNX16. These CC-dependent changes in dSNX16 association with Rab7-positive endosomes were not observed at the NMJ, where both dSNX16 and dSNX16^3A^ similarly reside on Rab5-positive endosomes ([Fig. 7, A--D](#fig7){ref-type="fig"}).

We then asked if expression of these dSNX16 variants affected the distribution of specific types of endosomes within the neuron. dSNX16^ΔCC^ caused a modest loss of Rab5 and Rab7 from the cell body. By contrast, dSNX16^3A^ promoted a modest accumulation of Rab5, but not Rab7, in the cell body. Neither CC variant had any effect at the NMJ ([Fig. 7, E and F](#fig7){ref-type="fig"}). Thus, while dSNX16 CC variants do not dramatically change the distribution of endosomes in the cell body, it is interesting to note that dSNX16^3A^ and dSNX16^ΔCC^ did have significant and opposite effects.

Finally, we examined colocalization of dSNX16 variants with GFP-myc-2xFYVE (FYVE), a reporter for PI(3)P-rich early endosomal compartments. Expression of FYVE abrogated our previously observed accumulation of dSNX16^3A^ relative to wild-type dSNX16 in the cell body (Fig. S4 C), suggesting it may not be behaving as a completely inert biosensor ([@bib60]). Given this caveat, FYVE colocalized with dSNX16 CC variants similarly to Rab5 at the NMJ and cell body ([Fig. 7, C and D](#fig7){ref-type="fig"}). Since dSNX16 and FYVE were both expressed using the GAL4-UAS system in motor neurons, we could examine their colocalization in axon bundles and found strong association with all CC variants (Fig. S4 E). Interestingly, dSNX16^3A^ caused an increase in overall FYVE levels in both the cell body and NMJ, as well as increased FYVE CoV in the cell body ([Fig. 7, E and F](#fig7){ref-type="fig"}; and Fig. S4 F), suggesting that it may prevent endosome maturation to such an extent that the reporter itself is stabilized and accumulates to high levels. For dSNX16^ΔCC^, we observed an increase in CoV with no change in total levels of FYVE in the cell body, axon, or NMJ ([Fig. 7, E and F](#fig7){ref-type="fig"}; and Fig. S4, D and F), arguing that dSNX16^ΔCC^ endosomes are enriched for PI(3)P, indicative of altered endosome maturation but with different consequences for endosome distribution compared with dSNX16^3A^.

Rab5 activates dSNX16 endosome association, distribution, and remodeling in vivo {#s10}
--------------------------------------------------------------------------------

Our previous observation that dSNX16^3A^-expressing animals exhibit synaptic overgrowth, opposite from the effects of *dSnx16* null mutants, suggests that dSNX16^3A^ is a dominant-active mutant ([@bib49]). Further, our in vitro data indicate that SNX16^3A^ potentiates the normal oligomerization and membrane tubulation activity of SNX16 and does not behave as a neomorphic gain of function. Therefore, we hypothesized that there may be mechanisms in vivo to activate dSNX16 toward a more dSNX16^3A^-like behavior for endosome association and deformation. We tested whether manipulations of Rab5 or Rab7 could activate dSNX16 based on our colocalization results with these GTPases. Strikingly, similar to dSNX16^3A^-expressing animals, overexpressing a constitutively active Rab5 transgene (Rab5^CA^) enhanced wild-type dSNX16-GFP punctate localization at the proximal axon (where this phenotype is highly robust; Fig. S2 D) and concomitantly enriched dSNX16 in the cell body ([Fig. 8, A--C](#fig8){ref-type="fig"}). By contrast, in Rab5^DN^-expressing animals, dSNX16 exhibited primarily cytoplasmic localization, which is the opposite of dSNX16^3A^- and Rab5^CA^-expressing animals ([Figs. 8 B](#fig8){ref-type="fig"} and S5 A). dSNX16 levels were also elevated in all compartments in Rab5^DN^-expressing animals.

![**Manipulations of endosomal trafficking alter wild type dSNX16 endosome structure, localization and distribution in the neuron. (A)** Representative images of animals expressing VGlut-GAL4-driven UAS-*dSnx16*-GFP together with Rab5^CA^, or Rab7^CA^ at the NMJ, the proximal axon, and the cell body. myr-mRFP serves as a UAS control. **(B)** dSNX16-GFP mean intensity quantification at the NMJ and the cell body. **(C)** CoV of dSNX16-GFP at proximal axon. **(D)** Representative SIM images of animals expressing VGlut-GAL4-driven UAS-*dSnx16*-GFP together with Rab5^DN^ or Rab5^CA^ at the cell body. L, left panel; R, right panel. **(E)** Representative SIM images of animals expressing VGlut-GAL4--driven UAS-*dSnx16*-SNAP variants together with Rab5^CA^ in the *dSnx16* null background. Quantification is from ≥23 NMJs, 35 axons, or 57 cell bodies analyzed using a Kruskal--Wallis test followed by Dunn's multiple comparisons test. Intensity measurements were normalized to mean intensity in the wild-type dSNX16 condition. All images show 2D maximum intensity projections of confocal stacks unless noted otherwise. Data are shown as box-and-whisker plots with all data points superimposed. \*\*, P \< 0.01; \*\*\*, P \< 0.001. ns, not significant. Scale bars, 10 µm.](JCB_201811074_Fig8){#fig8}

Next, since dSNX16 in Rab5^CA^-expressing animals exhibited dSNX16^3A^-like behaviors, we tested whether Rab5 can also modulate dSNX16 tubule localization in the cell body ([Fig. 8 D](#fig8){ref-type="fig"}). We found that Rab5^DN^ and Rab5^CA^ dramatically affected dSNX16-decorated endosome structures. dSNX16 localized to exaggerated elongated threads in Rab5^CA^-expressing animals, consistent with more tubulated structures observed in dSNX16^3A^-expressing animals, while in Rab5^DN^-expressing animals, fewer tubulated dSNX16 endosomes were observed, similar to dSNX16^ΔCC^. We then asked if Rab5^CA^-induced endosome tubulation depended on the CC domain of SNX16. Indeed, we found that Rab5^CA^ was able to tubulate endosomes in animals expressing dSNX16 or dSNX16^3A^ as their only source of SNX16, but not in animals expressing dSNX16^ΔCC^ ([Fig. 8 E](#fig8){ref-type="fig"}), providing strong evidence that this tubulation effect occurs specifically via the CC domain of SNX16. Notably, endosomes were still enlarged, suggesting that Rab5^CA^ can still activate other effectors in the absence of the SNX16 CC domain.

Finally, we tested whether Rab7 similarly affected SNX16 endosome association and distribution. We found that dSNX16 was strongly concentrated at the NMJ in Rab7^CA^-expressing animals, consistent with previous findings ([@bib1]), and was also largely depleted from the cell body ([Fig. 8, A and B](#fig8){ref-type="fig"}). By contrast, dSNX16 was slightly enriched at the cell body in Rab7^DN^-expressing animals. Thus, Rab7 manipulations shifted the distribution of dSNX16 between the NMJ and the cell body in the opposite direction of Rab5 manipulations but did not affect dSNX16 endosome association, suggesting that Rab7-dependent endosome distribution effects occur downstream of SNX16 endosome association.

Discussion {#s11}
==========

Here, we propose a working model for SNX16 in regulating neuronal growth factor signaling by controlling endosomal tubulation and distribution ([Fig. 9](#fig9){ref-type="fig"}). At the molecular level, SNX16, via its CC domain, oligomerizes into higher-order assemblies that promote tubulation of PI(3)P-containing membranes. At the cellular level, the SNX16 CC domain is required for its endosomal localization in both mammalian cells and *Drosophila* motor neurons. In these neurons, activation of Rab5 and CC-dependent self-association of SNX16 promote accumulation of SNX16 endosomes in Rab5- and Rab7-positive tubulated compartments in the cell body and regulate the localization and activity of the synaptic growth-promoting BMP receptor Tkv. Our results suggest that higher-order assembly of SNX16 on endosomes can control compartment identity and distribution to regulate the signaling activities of receptors in neurons.

![**Working model for SNX16 function.** The SNX16 CC domain controls its higher-order assembly and membrane tubulation capabilities. In *Drosophila* motor neurons, SNX16 oligomerization promotes its endosome association and redistribution from Rab5-positive endosomes at the NMJ to tubulated Rab5- and Rab7-positive endosomes in the cell body containing the BMP receptor Tkv. SNX16 oligomerization may be regulated by Rab GTPases and/or PI(3)P levels in vivo.](JCB_201811074_Fig9){#fig9}

Membrane tubulation activity of SNX16 {#s12}
-------------------------------------

SNX16 is selectively localized to dynamic tubular late-endosome structures in vivo ([@bib7]), but its function on these structures has been unclear. Here, we provide direct evidence that SNX16 can generate membrane tubules via CC domain--mediated higher-order assembly ([Fig. 3](#fig3){ref-type="fig"}). Interestingly, SNX16 does not contain predicted membrane remodeling domains such as the amphipathic helices or BAR domains found in the SNX-BAR subfamily ([@bib46]; [@bib59]) and therefore may deform membranes by one of several potential (and nonexclusive) mechanisms ([@bib43]; [@bib42]). First, higher-order assemblies of SNX16 may form a scaffold that imposes membrane curvature, as has been proposed for oligomers composed of Retromer and the PX-only protein SNX3 ([@bib38]). This model is supported by our cross-linking results and the reduced FRAP recovery we observe for SNX16 under conditions in which tubules form ([Fig. 2](#fig2){ref-type="fig"}), as well as previous results indicating multivalent self-association of SNX16 via the PX and CC domains ([@bib11]). High-resolution EM studies of SNX16-decorated tubules will be required to resolve the oligomeric state and organization of these SNX16 assemblies. Second, the predicted unstructured regions in the N- and C-termini of SNX16 ([Fig. 1 A](#fig1){ref-type="fig"}) may facilitate the scaffolding-induced membrane tubulation via protein crowding ([@bib55], [@bib56]; [@bib64]). Third, the hSNX16 structure indicates that the hydrophobic residue F220, which is required for membrane binding, is positioned to penetrate into the membrane ([@bib62]), potentially leading to wedging-induced membrane curvature. Indeed, our observation that higher-order assemblies of SNX16 are salt insensitive for membrane binding suggest that these interactions may be mediated by such hydrophobic interactions ([Fig. 1, E and F](#fig1){ref-type="fig"}). Further biophysical studies of SNX16 membrane insertion will be required to test these hypotheses.

Role of dSNX16 in endosome distribution {#s13}
---------------------------------------

In addition to regulating the structure of neuronal endosomes, we made the unexpected finding that self-association promotes SNX16 redistribution from Rab5-positive endosomes at the axon terminal to Rab5- and Rab7-positive endosomes in the cell body. One possibility is that SNX16-positive structures are independently generated in the cell body and at the NMJ, similar to local recycling of Trk receptors ([@bib2]). Alternatively, SNX16 endosomes may play a role in long-range transport of cargo from the NMJ to the cell body. In favor of this model, mammalian SNX16 copurifies with retrogradely transporting, maturing compartments in neurons ([@bib16]). Further, we observed occasional retrograde cotransport of dSNX16 and Tkv particles ([Fig. 6 E](#fig6){ref-type="fig"} and Videos 1 and 2), suggesting that SNX16 endosomes may play an active role in Tkv retrograde transport. Indeed, exit of Rab7-positive endosomes from the NMJ promotes BMP signaling ([@bib36]), similar to TrkA receptor retrograde transport ([@bib63]). However, many axonal dSNX16 particles are stationary, and many motile Tkv particles do not contain dSNX16, so while it is possible that a small number of transport carriers are sufficient to mediate Tkv redistribution, we cannot exclude the existence of additional, SNX16-independent transport carriers for both active and inactive Tkv. Taken together, our findings suggest that the endosome maturation/tubulation that occurs with SNX16 self-association is coupled with enhanced retrograde transport.

Role of dSNX16 tubules in vivo {#s14}
------------------------------

Consistent with its in vitro tubulation capability ([Fig. 3](#fig3){ref-type="fig"}) and the tubular localization of hSNX16 in HeLa cells ([@bib7]), we observed wild-type dSNX16 on tubular structures that exclude the Tkv receptor at *Drosophila* motor neuron cell bodies ([Fig. 6 H](#fig6){ref-type="fig"}). The exclusion of Tkv from SNX16-decorated tubules stands in contrast to SNX-PX-BAR--decorated tubules, which colocalize with and sort cargo directly ([@bib14]), suggesting that different SNXs may either promote or restrict cargo transport in the endosomal pathway. The tubule localization of SNX16 is CC domain dependent, and we observed increased numbers of tubular compartments in our hyperoligomerized SNX16^3A^ mutant ([Fig. 5 B](#fig5){ref-type="fig"}). This mutant also promotes BMP receptor accumulation in endosomes ([Fig. 6](#fig6){ref-type="fig"}) as well as transcription of BMP target genes such as *trio* ([@bib49]). Taken together, our results raise the intriguing possibility that SNX16 tubules promote signaling by antagonizing BMP receptor down-regulation, perhaps by removing other cargoes that would otherwise promote endosome maturation or lysosome fusion. Consistent with this hypothesis, overexpression of SNX16 blocks escape of viral RNA from multivesicular bodies ([@bib35]). Further, multivesicular bodies accumulate at SNX16^3A^-expressing NMJs ([@bib49]), and SNX16 is found on intermediate Rab7- and LAMP1-positive, but not later LBPA- or CD63-positive, endosomes ([@bib7]), suggesting that it may prevent endosome maturation.

Somewhat surprisingly, our dSNX16^ΔCC^ mutant also promoted BMP-dependent synaptic growth ([Fig. 6, A--C](#fig6){ref-type="fig"}), despite exhibiting reduced endosomal localization and endosome tubulation in the cell body ([Fig. 5](#fig5){ref-type="fig"}). This suggests a more complex and interesting model than the simple idea that tubulation alone promotes endosomal BMP signaling and that dSNX16^ΔCC^ should behave like a loss-of-function mutant. Despite being expressed at lower levels, we found that dSNX16^ΔCC^ colocalized as well as wild-type dSNX16 to Tkv-positive endosomes in the cell body and axon ([Fig. 6](#fig6){ref-type="fig"}) and increased the distribution of FYVE from the cytosol to endosomes (Fig. S4 F). This suggests that Tkv is enriched in SNX16^ΔCC^-positive PI(3)P-rich endosomes. Interestingly, similarly PI(3)P-rich endosomes suppress EGFR inactivation in nonneuronal cell lines ([@bib8]) and dynein-mediated axonal transport in hippocampal neurons ([@bib37]), indicating that they may be permissive for signaling.

Synthesizing these results, we hypothesize that SNX16^ΔCC^ endosomes represent a block at an early, highly signal-permissive state that can nonetheless still target cargo for degradation, resulting in net lower levels of Tkv, Rab5, and Rab7 in the cell body. SNX16^3A^ endosomes on the other hand may represent a more mature blocked state in which endosomes accumulate in the cell body and protect Tkv from degradation. Our data overall suggest that the CC domain is required to attenuate signaling at endosomes (perhaps by preventing endosome maturation or sequestering Tkv from cytoplasmic signaling), while an overactive CC blocks progression of Tkv to degradation.

In vivo regulation of dSNX16 oligomerization {#s15}
--------------------------------------------

*dSnx16*^3A^ and *dSnx16* null mutants exhibit opposite synaptic growth phenotypes ([@bib49]), and dSNX16^3A^ potentiates the normal in vitro activities of SNX16, suggesting that it functions as a dominant-active mutant and that in vivo mechanisms of wild-type SNX16 regulation might similarly promote its oligomerization and endosome tubulation activities. Manipulation of Rab5 and Rab7 has previously been shown to affect dSNX16 levels at the NMJ ([@bib1]), suggesting that these endosome regulators may control SNX16 activity. We found that GTP-locked Rab5^CA^ promotes endosome association, CC-dependent tubulation, and redistribution of wild-type dSNX16 from the NMJ to the cell body (identically to dSNX16^3A^), while GDP-locked Rab5^DN^ produces the opposite phenotypes, suggesting that dSNX16 oligomerization and endosome tubulation may be regulated by Rab5 ([Fig. 8](#fig8){ref-type="fig"}). This may occur via direct effects on SNX16 CC interactions via an as-yet-unknown Rab5 effector. Alternatively, Rab5 may regulate SNX16 activity by increasing PI(3)P levels ([@bib53]), which can promote SNX16 membrane binding and remodeling in vitro. Separating these mechanisms will require developing tools to distinguish SNX16 CC-mediated oligomerization from PI(3)P binding. By contrast, manipulation of Rab7 did not directly phenocopy the effects of SNX16 oligomerization and instead primarily resulted in the redistribution of SNX16 between the cell body and NMJ. Thus, Rab7 regulates transport of SNX16 endosomes, but not assembly of SNX16 on these endosomes. Our previous results indicating that SNX16 acts downstream of the membrane-remodeling F-BAR/SH3 protein Nwk, which constrains synaptic growth signaling ([@bib49]), suggest that Nwk acts antagonistically to the Rab5 pathway to limit SNX16 activity. Further studies will be required to determine where Nwk and other potential SNX16-interacting factors act in this pathway and integrate opposing SNX16 regulatory mechanisms that control endosome maturation and distribution ([Fig. 9](#fig9){ref-type="fig"}).

Materials and methods {#s16}
=====================

Plasmid construction {#s17}
--------------------

Full-length hSNX16 was cloned into pcDNA3.1 using Gateway technology (Invitrogen) from Addgene plasmid 23617. hSNX16 variants were generated in this construct by site-directed mutagenesis. hSNX16^3A^ (E231A, E234A, and E235A) was generated with the following primer set: forward, 5′-CCT​AGA​AGA​AAG​CAG​GGC​ATT​CTG​TGC​GAC​TTT​AGC​CGC​GAC​AAA​CTA​CCG​CTT​ACA​GAA​AGA​AC-3′; and reverse, 5′-GTT​CTT​TCT​GTA​AGC​GGT​AGT​TTG​TCG​CGG​CTA​AAG​TCG​CAC​AGA​ATG​CCC​TGC​TTT​CTT​CTA​GG-3′. hSNX16^ΔCC^ (aa 230--278 deletion) was generated with the following primer set: forward, 5′-GCC​TAG​AAG​AAA​GCA​GGG​CAT​TCC​CTG​AAG​AAT​CAC​TGG​ATG​TG-3′; and reverse, 5′-CAC​ATC​CAG​TGA​TTC​TTC​AGG​GAA​TGC​CCT​GCT​TTC​TTC​TAG​GC-3′. hSNX16^Y145A^ was generated with the following primer set: forward, 5′-CCC​CAG​AAG​AAA​GCT​GGG​TAG​TTT​TCA​GAA​GAG​CTA​CTG​ACT​TCT​CTA​GGC​TTA​ATG​AC-3′; and reverse, 5′-GTC​ATT​AAG​CCT​AGA​GAA​GTC​AGT​AGC​TCT​TCT​GAA​AAC​TAC​CCA​GCT​TTC​TTC​TGG​GG-3′. For expression in rat hippocampal neurons, hSNX16 and mutants were amplified via PCR (with the primer set forward, 5′-GCG​CGG​AAT​TCC​CAT​GGC​AAC​TCC​TTA​TGT​CCC-3′; and reverse, 5′-GCG​CGC​TCG​AGC​TAG​TCT​TCT​TCA​GCA​TCA​TAT​GCC​A-3′) and cloned into pCMV-myc. For expression and purification of hSNX16 variants, wild-type and mutant hSNX16 were amplified via PCR and cloned into pGEX-6P (GE Healthcare; with the following primer set: forward, 5′-GCG​CGG​AAT​TCC​ATG​GCA​ACT​CCT​TAT​GTC​CC-3′; and reverse, 5′-GCG​CGC​TCG​AGC​TAG​TCT​TCT​TCA​GCA​TCA​TAT​GCC​A-3′) and into pTrcHis-Xpress-SNAP vectors ([@bib30]; with the following primer set: forward, 5′-GCG​CGG​GAT​CCA​TGG​CAA​CTC​CTT​ATG​TCC​C-3′; and reverse, 5′-GCG​CGG​GCG​CGC​CCA​CCC​TTG​TCT​TCT​TCA​GCA​TCA​TAT​GCC​A-3′). All constructs were verified by sequencing. pGEX-4T-hSNX1 was a gift from P. Cullen (Indiana University, Bloomington, IN).

Protein purification {#s18}
--------------------

BL21 DE3 cells transformed with the indicated constructs were grown to log phase and induced with 0.4 M IPTG at 18°C for 12 h. GST fusion proteins and His-Xpress-SNAP--tagged proteins were purified as previously described ([@bib5]; [@bib30]).

GST fusion proteins were purified from *Escherichia coli* extracts on glutathione agarose resins (Thermo Fisher Scientific), followed by PreScission protease (GE Healthcare) cleavage at 4°C for 16 h. Released SNX16 variants were then gel filtrated through a Superdex 75 column in 20 mM Tris, 50 mM KCl, 0.1 mM EDTA, and 0.5 mM DTT, pH 7.5. Peak fractions were determined from SDS-PAGE analysis, concentrated, aliquoted, flash frozen in liquid N~2~, and stored at −80°C. For BS^3^ cross-linking assays, proteins were gel filtered in 20 mM Hepes buffer instead of 20 mM Tris buffer.

His-Xpress-SNAP--tagged proteins were purified from *E. coli* extracts on nickel-nitrilotriacetic acid agarose beads (Qiagen), followed by gel filtration on a Superose 12 column (GE Healthcare) in 20 mM Tris, 50 mM KCl, 0.1 mM EDTA, and 0.5 mM DTT, pH 7.5. The concentrated peak fractions were supplemented with 1 mM DTT and incubated at 25°C for 2 h with a 5-M excess of SNAP-Surface Alexa Fluor 488 (New England Biolabs). The final protein product was exchanged into 20 mM Tris, 50 mM KCl, 0.1 mM EDTA, and 0.5 mM DTT, pH 7.5, using a PD-10 desalting column (GE Healthcare), aliquoted, flash frozen in liquid N~2~, and stored at −80°C.

In vitro liposome cosedimentation and BS^3^ cross-linking assays {#s19}
----------------------------------------------------------------

Lipid cosedimentation assays were conducted as previously described ([@bib5]). DOPS, PI(3)P, and rhodamine PE were obtained from Avanti Polar Lipids; DOPC and DOPE were obtained from Echelon Biosciences. To generate liposomes, lipids were mixed in the indicated ratios and dried under a stream of argon gas, followed by 1 h under vacuum. Lipid films were then hydrated in 20 mM Hepes, pH 7.5, and 100 mM NaCl for 2 h at 37°C to a final concentration of 1.5 mM.

In the cosedimentation assays (all performed in triplicate), 10 µl of 1.5 mM liposomes (0.5 mM final concentration) with the indicated PI(3)P composition (0.05%, 1%, 2.5%, 5%, and 10%) was incubated with 20 µl of 3 µM protein (2 µM final concentration, in 20 mM Hepes, pH 7.5, and 100 mM NaCl) for 30 min at room temperature, followed by centrifugation at 18,000 ×g for 20 min at 4°C. For salt sensitivity experiments, proteins and liposomes were incubated in 100 mM NaCl or 400 mM NaCl for 45 min or 100 mM NaCl for the first 30 min then in 400 mM NaCl for the following 15 min. Proteins were prespun under the same conditions before incubation with lipids. To measure membrane-bound fraction, pellets and supernatants were separated and equal amounts were fractionated by SDS-PAGE, stained with Coomassie, and quantified by densitometry on a LI-COR Odyssey instrument. Membrane-bound hSNX16 fraction was quantified as hSNX16 intensity in the pellet/(hSNX16 intensity in the pellet + hSNX16 intensity in the supernatant).

For BS^3^ cross-linking assays, 10 µl of 1.5 mM 1% PI(3)P liposomes (0.5 mM final concentration) was incubated with 20 µl of 7.5 µM protein (5 µM final concentration) for 30 min at room temperature with BS^3^ (Thermo Fisher Scientific) at the indicated concentrations (125 nM, 2.5 µM, 5 µM, 12.5 µM, and 25 µM in the liposome cosedimentation assay; 25 nM, 50 nM, 125 nM, 2.5 µM, 5 µM, 12.5 µM, and 25 µM in the Hepes buffer alone assay). 1 µl of 1 M Tris was added to each reaction to stop cross-linking for 15 min at room temperature. Samples were then centrifuged, run on 7.5% SDS-PAGE gel, and imaged on a LI-COR Odyssey instrument as described in cosedimentation assays.

To account for the fact that hSNX16 pellet fraction and supernatant fraction were run on different gels in the BS^3^ cross-linking assays, membrane-bound hSNX16 variants were quantified from the pellet and supernatant gels individually. In the pellet-fraction gels, hSNX16 intensity measured in the no-BS^3^ condition was considered the liposome-bound protein intensity. Intensity measurements were normalized to wild-type hSNX16 intensity. In the supernatant-fraction gels, intensity measured in 0% PI(3)P liposome supernatant was considered the total protein intensity; intensity measured in the no-BS^3^ condition was considered the unbound protein intensity. The membrane-bound hSNX16 fraction was quantified as (total protein intensity − unbound protein intensity)/total protein intensity. To control for background, pellet-fraction gels or supernatant-fraction gels of hSNX16 variants were stained in the same container and scanned in one image.

In vitro GUV assays and FRAP analysis {#s20}
-------------------------------------

GUVs were generated by electroformation in a Vesicle Prep Pro device (Nanion Technologies) or through gentle hydration in 5 mM Hepes and 300 mM sucrose, pH 7.5, as described previously ([@bib30]). Approximately 30 µM GUVs (300 nM PI(3)P) was mixed with 100 nM or 500 nM SNAP-tagged proteins in 10 mM Hepes and 150 mM KCl, pH7.5; incubated for 45 min; and imaged in µ-Slide Angiogenesis devices (ibidi). All GUV stacks were acquired at 0.5-µm steps using SlideBook software (3I) on a Marianas spinning-disk confocal system (3I), which consists of an Observer Z1 microscope (Carl Zeiss) equipped with a CSU-X1 spinning-disk confocal head (Yokagawa) and a QuantEM 512SC EM charge-coupled device (CCD) camera (Photometrics) with a 100× (NA 1.45) oil-immersion objective at room temperature. Stack images were exported as tiffs into FIJI (National Institutes of Health) for quantification.

To quantify the percentage of tubulated GUVs, the lipid channel (rhodamine PE) was used to identify unilamellar vesicles. The protein channel (SNAP 488) was then used to count tubules for each GUV. The number of tubules reflected tubules observed in the whole Z stack.

For FRAP experiments, 1% agarose in 10 mM Hepes and 150 mM KCl, pH 7.5, was added to limit GUV mobility (0.33% final agarose percentage). GUVs were imaged for 6 min at 2-s intervals, with a pause for bleaching after time point 10 (the 20th second, shown as time point 0 in graphs). Signal intensity over time from a nonbleached region of the same GUV was used to correct for photobleaching. Protein fluorescence was further normalized by subtracting the intensity at bleaching (time point 10) from all time points and divided by prebleach intensity. Because lipid fluorescence recovered before the first time point was recorded (time point 10), it was not normalized and was only corrected for photobleaching.

Negative staining and EM {#s21}
------------------------

Liposomes for negative staining were generated at 1.5 mM as described in liposome cosedimentation assays with 10% PI(3)P and extruded through a 200-nm filter (Avanti Polar Lipids). Liposomes (0.5 mM) were incubated with protein for 30 min. Samples were applied to copper grids coated with continuous carbon, negatively stained with 2% uranyl acetate (JT Baker Chemical), and imaged using a Morgagni 268 transmission electron microscope (FEI) operating at 80 kV and equipped with a 1,000 × 1,000 CCD camera (Gatan).

Mammalian cell culture, transfection, immunostaining, and imaging {#s22}
-----------------------------------------------------------------

Dissociated rat hippocampal neurons were cultured on a feeder layer of astrocytes as previously described ([@bib24]). Briefly, a layer of confluent astrocytes was generated by plating the cells onto 12-mm glass coverslips coated with poly-D-lysine (20 µg/ml) and laminin (3.4 µg/ml) in 24-well plates. Dissociated hippocampi from embryonic dat 18 rat embryos were plated on this layer of astrocytes at a density of 80,000 cells per well and grown in Neurobasal medium supplemented with B27 (Thermo Fisher Scientific) at 37°C. Neurons were transfected at day in vitro (DIV) 2 using the calcium phosphate transfection method ([@bib61]) at 500 ng/well per plasmid and fixed on DIV 7 with 4% PFA + 4% sucrose solution in PBS. The pCMV-GFP plasmid was cotransfected with myc-hSNX16 variants to visualize individual neurons. Fixed neurons were then incubated with mouse anti-Myc antibody (9e10 1:500; A5963; Sigma) diluted in gelatin blocking buffer at 4°C overnight in a humidified chamber, followed by 2-h secondary antibody incubation at room temperature. Coverslips were then washed and mounted on glass microscope slides with Aquamount (Lerner Laboratories).

Human adenocarcinoma HeLa and MCF7 cells and human osteosarcoma U2OS cells (ATCC) were grown in standard DMEM (GIBCO BRL Life Technologies) supplemented with 2 mM L-glutamine (Thermo Fisher Scientific) and 10% FBS at 37°C with 5% CO~2~. Cells were seeded on collagen I-coated (50 µg/ml, Advanced BioMatrix) 12-mm glass coverslips in 24-well plates before transfection. HeLa cells and U2OS cells were transfected at 40--50% confluence using polyethylenimine (Polysciences) as previously described ([@bib27]). MCF7 cells were transfected at 70% confluence using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer's instructions. Cells were fixed in 4% PFA in PBS 24 h after transfection. Fixed U2OS cells were incubated with mouse anti-EEA1 antibody (clone 14 1:1,000; 610457; BD Biosciences) for 1 h in a humidified chamber, followed by 1-h secondary antibody incubation at room temperature. Coverslips were washed and mounted on glass microscope slides with Aquamount (Lerner Laboratories).

HeLa cells were imaged on a Marianas spinning-disk confocal system (as described above for GUVs). All other cell types were imaged at room temperature on an Andor spinning-disk confocal system, which consists of a Nikon Ni-E upright microscope equipped with a Yokogawa CSU-W1 spinning-disk head and an Andor iXon 897U EMCCD camera. HeLa, U2OS, and MCF7 cells were acquired in NIS Elements AR software (Nikon) with a 100× (NA 1.45) oil-immersion objective at 0.2-µm steps. Cultured rat hippocampal neurons were acquired with a 60× (NA 1.4) oil-immersion objective at 0.3-µm steps. Images for each independent experiment were acquired and shown with identical settings for all conditions. To quantify CoV of myc-hSNX16 intensity in the hippocampal neuron cell bodies, sum projections were generated from individual Z stacks with FIJI ([@bib51]). Cell bodies were manually outlined in the GFP channel for transfected neurons. The mean fluorescence intensity and intensity standard deviation of myc-hSNX16 variants were then measured in that area to calculate CoV (standard deviation/mean fluorescence intensity). To quantify hSNX16 and hSNX16^3A^ pixel intensity distributions in single-slice HeLa cells, cells were manually outlined. Images were normalized to the mean hSNX16 intensity in this area, and pixel intensity distributions were calculated using the Sixteen Bit Histogram plugin in ImageJ. Data were binned as indicated and graphed using Prism software (GraphPad).

*Drosophila* stocks, culture, and imaging {#s23}
-----------------------------------------

Flies were cultured using standard media and techniques. UAS-dSnx16-SNAP plasmids were constructed into pUAST-AttB ([@bib6]) via Gibson assembly from previously generated UAS-dSnx16-GFP plasmids ([@bib49]) using the following primers: forward, 5′-GAA​TTC​GTT​AAC​AGA​TCT​GCG​GCC​GCC​CCC​TTC​ACC​AT-3′; reverse, 5′-TGG​TGC​GCT​TGC​ATG​CGA​TAT​CAA​CCA​CTT​TGT​ACA​AGA​AAG​C-3′; forward, 5′-TAT​CGC​ATG​CAA​GCG​CAC​CAC​CCT​GGA​T-3′; and reverse, 5′-TAG​AGG​TAC​CCT​CGA​GCC​GCT​TAA​TGG​GAT​CCT​GGC​GCG-3′). dSNX16^ΔCC^ (aa 345--393 deletion) was generated by site-directed mutagenesis with the following primer set: forward, 5′-CCA​TGG​AGG​AGT​GTC​GTG​CAA​TTT​GCT​CGC​ACT​GCT​CCT​CAG​CTA​GCG-3′; and reverse, 5′-CGC​TAG​CTG​AGG​AGC​AGT​GCG​AGC​AAA​TTG​CAC​GAC​ACT​CCT​CCA​TGG-3′. Sequence-verified constructs were injected into w1118 flies at AttP40 ([@bib39]) at Rainbow Transgenic Flies. Previously described fly stocks include VGlut-GAL4 (X; [@bib15]), *Snx16*^Δ1^, Df(2R)Exel7150, UAS-dSnx16-GFP, UAS-dSnx16^3A^-GFP ([@bib49]), UAS-Tkv-mCherry ([@bib18]), GFP-Rab5^KI^ ([@bib21]), YFP-myc-Rab7^KI^ ([@bib19]), UAS-Rab7^DN^ (Rab7^T22N^; [@bib3]), UAS-Rab11^DN^ (Rab11^N124I^; [@bib50]), UAS-Rab11^CA^ (Rab11^Q70L^; [@bib20]), UAS-hTfR ([@bib57]), and UAS-Tkv^Q199D^ ([@bib26]). Larvae overexpressing a Rab5^CA^ in motor neurons exhibit grossly normal crawling behavior and eclose as adults at normal rates, while larvae overexpressing Rab7^CA^ crawl more slowly and eclose at lower rates. The following stocks were obtained from the Bloomington Drosophila Stock Center (stock number indicated in parentheses): UAS-myr-mRFP (BL7118), UAS-Rab5^DN^ (Rab5^S43N^; BL42703), UAS-Rab5^CA^ (Rab5^Q88L^; BL43335), UAS-Rab7^CA^ (Rab7^Q67L^; BL42707), UAS-Myc-2xFYVE-GFP (BL42712), *wit*^A12^(BL5173), and *wit*^B11^ (BL5174).

For protein localization in *Drosophila*, flies were cultured at controlled density at 25°C. Wandering third-instar larvae (a minimum of six per genotype) were dissected in calcium-free HL3.1 saline ([@bib22]) and then fixed in HL3.1 (or PBS for pMad staining) containing 4% formaldehyde for 15 min. Fillets were then stained with mouse α-Rab11 (clone 47, 1:100, 4°C overnight; 610656; BD Biosciences), mouse α-hTfR (1:2,000, 2 h at room temperature; 236-15375; Invitrogen), mouse α-Synapsin (1:1,000, 4°C overnight; 3C11; Developmental Studies Hybridoma Bank), or rabbit α-pMad ([@bib45]; 1:1,000, 4°C overnight). Larvae expressing dSNX16-SNAP variants were stained for 15 min with 2 µM SNAP-Surface 488 (New England Biolabs) or for 2 min with 0.5 µM JF549-cpSNAP-tag ligand, both diluted in PBS (Luke Laevis, Janelia Research Campus, Ashburn, VA; [@bib31]), followed by 1 h of goat α-HRP 647 staining (1:250; 123-605-021; Jackson ImmunoResearch Laboratories) at room temperature. For subcellular and colocalization analysis, type 1b NMJs from segment A2 and A3 on muscle 4 were imaged at room temperature on a Nikon Ni-E upright spinning disk confocal microscope as described above using a 60× NA 1.4 or 100× NA 1.45 oil-immersion objective; two fields of proximal axons were imaged within 100 µm of the ventral ganglio, and four sets of MNISN-I cell bodies were imaged from the posterior end of the ventral ganglion ([@bib12]). Images for each independent experiment were acquired with identical settings for all genotypes and are shown at identical contrast except where indicated. Single NMJ stack images, single axon stack images, and single-slice cell body images were manually cropped for intensity quantification. For analysis of NMJ morphology, type 1b NMJs from segment A2 and A3 on muscle 4 were imaged. α-Synapsin was used for manual bouton counting in ImageJ, from 2D projections of confocal stacks. Only type Ib innervation was quantified.

Mean fluorescence intensity and CoV were performed on background-intensity--subtracted sum intensity projections at the NMJ and proximal axons and on single slices at the cell body, with the exception that CoV was quantified on maximum intensity projection at the proximal axon in [Fig. 5 C](#fig5){ref-type="fig"} because of the strong cytoplasmic localization. The PCC was calculated using Coloc2 (FIJI) on maximum intensity projections at the NMJ and proximal axons and on single slices at the cell body. For pMad levels at the ventral ganglion, mean pMad intensities were measured within a single, central slice of dSNX16-positive cell bodies.

For live imaging, wandering third-instar larvae were dissected in room temperature HL3.1, leaving the central nervous system and axons intact. Dissected larvae were then transferred onto a glass slide for imaging in a drop of HL3.1, and a coverslip was affixed to the glass slide by double-sided tape (3M). Segmental nerve bundles were imaged ∼100 µm from the ventral ganglion at 1.5 s per Z stack. Larvae were imaged for a maximum of 30 min after dissection. All samples were imaged at room temperature using a Nikon Ni-E upright spinning disk confocal microscope as above, enabled for simultaneous two-color acquisition with a TuCam device (GFP-mCherry 532/617 mirror; Andor) and two iXon 897U EMCCD cameras. For axonal transport quantification, videos were registered using FIJI MultiStackReg when necessary, and a kymograph was generated using the FIJI KymographBuilder by drawing a straight line from the proximal to the distal end of the in-focus region of the axon bundle. Retrograde, anterograde, and stalled particles were manually counted from the SNX16-GFP channel and then correlated with Tkv signal.

For SIM, images in the cell body were collected at room temperature at 0.2-µm steps on a Nikon N-SIM instrument equipped with an Apo total internal reflection fluorescence 100× (NA 1.4) oil-immersion objective. Images were acquired using a violet-to-red diffraction grating at three angles and five phases of illumination, producing 15 raw images for SIM analysis, and reconstructed with default stack reconstruction setting in NIS Elements software. SIM images were not acquired at identical settings due to the sensitivity of SIM reconstruction to signal intensity.

Statistical analyses {#s24}
--------------------

All errors shown are mean ± SEM in xy and column graphs, as well as for quantifications reported in the text. All box-and-whisker plots are superimposed with individual data points. The box extends from the 25th to 75th percentiles with the median in the middle, and the whiskers mark the lowest data point to the highest. Data were tested for normality using a D'Agostino--Pearson omnibus normality test, and statistical significance was calculated using a one-way ANOVA followed by Tukey's test, Kruskal--Wallis tests followed by multiple Dunn comparisons, or a Mann--Whitney *U* test in Prism software (GraphPad) as indicated in the figure legends (\*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001). Comparisons are to the leftmost genotype in each bar graph, unless indicated otherwise by horizontal bars.

Online supplemental material {#s25}
----------------------------

Fig. S1 shows quantification of liposome binding of hSNX16 CC variants, cross-linking of hSNX16 CC variants without liposomes, and representative time-lapse images and FRAP quantification. Fig. S2 shows a schematic of the NMJ, proximal axon, and cell body and representative images and quantification of dSNX16 levels in dSNX16-GFP and dSNX16^3A^-GFP lines. Fig. S3 shows representative images and quantification of Tkv-mCherry levels and localization in dSNX16-GFP and dSNX16^3A^-GFP lines as well as representative images and the quantification of hTfR levels and localization in dSNX16-SNAP lines. Fig. S4 shows representative images and quantification of dSNX16 CC variant endosomal localization. Fig. S5 shows representative images and quantification of wild-type dSNX16 levels upon Rab manipulation. Videos 1 and 2 show retrogradely cotransported dSNX16-GFP and Tkv-mCherry particles along segmental axon bundles of *Drosophila* third-instar larvae.
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